Koers Immunotech Laboratories, Inc. Other OTC
Aandelen
IMMB
US45254F2039
Biotechnologie & Medisch Onderzoek
Omzet * | - | Omzet 1 * | - | Marktkapitalisatie | 57,5K 52,79K |
---|---|---|---|---|---|
Nettowinst (verlies) * | - | Nettowinst (verlies) 1 * | - | EV/omzet * | - |
Nettoliquiditeiten * | - 0 | Nettoliquiditeiten 1 * | - 0 | EV/omzet 1 * | - |
K/w-verhouding * |
-
| K/w-verhouding 1 * |
-
| Werknemers | - |
Dividendrendement * |
-
| Dividendrendement 1 * |
-
| Vrij verhandelbaar | 99,34% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Harry Zhabilov
CHM | Chairman | 57 | 01-12-07 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Harry Zhabilov
CHM | Chairman | 57 | 01-12-07 |
Director/Board Member | 59 | 04-02-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+19,33% | 125 mld. | |
+13,95% | 108 mld. | |
-3,53% | 24,57 mld. | |
+3,64% | 22,82 mld. | |
-10,35% | 18,19 mld. | |
-41,48% | 16,54 mld. | |
-12,62% | 16,5 mld. | |
+0,99% | 13,39 mld. | |
+21,79% | 11,1 mld. |